Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis

B Fialek, M Pruc, J Smereka, R Jas… - Cardiology …, 2022 - journals.viamedica.pl
Background: This meta-analysis outlines the role of elevated lactate dehydrogenase (LDH)
levels in assessing the severity of coronavirus disease 2019 (COVID-19). Methods: The …

Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis

L Szarpak, KJ Filipiak, A Skwarek, M Pruc… - Cardiology …, 2022 - journals.viamedica.pl
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia in the adult
population. Herein, is a systematic review with meta-analysis to determine the impact of …

[PDF][PDF] Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis

L Szarpak, M Pruc, A Gasecka… - Pol. Arch. Intern …, 2021 - researchgate.net
Introduction: Preliminary retrospective reports showed that zinc supplementation may
decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc …

[HTML][HTML] Infections as novel risk factors of atherosclerotic cardiovascular diseases: Pathophysiological links and therapeutic implications

P Szwed, A Gąsecka, M Zawadka, C Eyileten… - Journal of Clinical …, 2021 - mdpi.com
Atherosclerotic cardiovascular diseases (ASCVD) are the major cause of mortality
worldwide. Despite the continuous progress in ASCVD therapy, the residual risk persists …

COVID-19-induced coagulopathy: Experience, achievements, prospects

L Dubey, O Dorosh, N Dubey, S Doan… - Cardiology …, 2023 - journals.viamedica.pl
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …

[HTML][HTML] Prediction value of KREBS von den lungen-6 (KL-6) biomarker in COVID-19 patients: a systematic review and meta-analysis

M Matuszewski, L Szarpak, Z Rafique… - Journal of Clinical …, 2022 - mdpi.com
The SARS-CoV-2 (COVID-19) pandemic is a major issue that necessitates the use of cutting-
edge disease prediction models. The aim of the study was to assess the existing evidence …

Understanding of cytokines and targeted therapy in macrophage activation syndrome

S Tang, S Li, S Zheng, Y Ding, D Zhu, C Sun… - Seminars in Arthritis and …, 2021 - Elsevier
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of
systemic autoinflammatory/autoimmune diseases, generally systemic juvenile idiopathic …

[HTML][HTML] The sFlt-1/PlGF ratio in pregnant patients affected by COVID-19

K Kosinska-Kaczynska, E Malicka, I Szymusik… - Journal of Clinical …, 2023 - mdpi.com
COVID-19 in pregnant women increases the risk of adverse pregnancy outcomes, including
preeclampsia. This meta-analysis aimed to examine the effect of SARS-CoV-2 infection on …

Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis

L Szarpak, KJ Filipiak, A Gasecka, W Gawel… - Cardiology …, 2022 - journals.viamedica.pl
Background: Vitamin D is a likely candidate for treatment as its immune modulating
characteristics have effects on coronavirus disease 2019 (COVID-19) patients. It was sought …

Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients

B Fialek, C De Roquetaillade, M Pruc… - Annals of …, 2023 - Taylor & Francis
Background Mid-regional pro-adrenomedullin (MR-proADM) is useful for risk stratification in
patients with sepsis and respiratory infections. The study's purpose was to assess the …